
- Lilly’s weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk Reuters
- FDA approves Lilly’s Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions investor.lilly.com
- Lilly’s obesity pill gets US approval in challenge to Novo Yahoo Finance
- Oral Alternative to Ozempic May Be Even More Effective For Weight Loss ScienceAlert
- The FDA approves a new obesity pill, giving patients another option NPR






:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)



Recent Comments